Hexokinase II and VEGF expression in liver tumors: correlation with hypoxia-inducible factor-1α and its significance
- 31 January 2004
- journal article
- Published by Elsevier in Journal of Hepatology
- Vol. 40 (1) , 117-123
- https://doi.org/10.1016/s0168-8278(03)00503-8
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Vascular endothelial growth factor is up-regulated in the early pre-malignant stage of colorectal tumour progressionInternational Journal of Cancer, 1999
- Vascular endothelial growth factor-induced tumor angiogenesis and tumorigenicity in relation to metastasis in a HT1080 human fibrosarcoma cell modelInternational Journal of Cancer, 1999
- Hexokinase Type II: A Novel Tumor-Specific Promoter for Gene-Targeted Therapy Differentially Expressed and Regulated in Human Cancer CellsHuman Gene Therapy, 1999
- Expression of vascular endothelial growth factor in human hepatocellular carcinomaHepatology, 1998
- Cellular and developmental control of O2 homeostasis by hypoxia-inducible factor 1αGenes & Development, 1998
- Clinical significance of vascular endothelial growth factor and basic fibroblast growth factor gene expression in liver tumorHepatology, 1996
- Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension.Proceedings of the National Academy of Sciences, 1995
- Differences in expression and intracellular distribution of hexokinase isoenzymes in rat liver cells of different transformation stagesBiochimica et Biophysica Acta (BBA) - Gene Structure and Expression, 1994
- Remarkably enhanced expression of the type II hexokinase in rat hepatoma cell line AH130FEBS Letters, 1991
- Angiogenic FactorsScience, 1987